Integra LifeSciences Dermagran Hydrophilic Impregnated Gauze Wound Dressing 2" x 2", 25/BX

Dermagran Hydrophilic Impregnated Gauze Wound Dressing 2" x 2", 25/BX

Dermagran hydrophilic impregnated gauze wound dressing is a sterile 2 inch x 2 inch dressing for wound care needs. Buyers looking for a compact gauze dressing may choose it for clinical and care settings where a sterile format matters. This version includes Dermagran's zinc-nutrient dressing formulation and balanced pH technology, packed 25 per box.

Good Fit For

• Wound care supply purchasing
• Clinical dressing changes
• Care settings that require sterile dressings

Key Features

• Hydrophilic impregnated gauze wound dressing for wound care applications
• Sterile format supports workflows that require sterile dressings
• 2 inch x 2 inch size suits small dressing coverage needs
• Includes zinc-nutrient dressing formulation
• Made with balanced pH technology
• 25 dressings per box for routine purchasing and replenishment

Applications and Usage

• Stocking sterile gauze wound dressings for wound care
• Supporting dressing changes where a 2 inch x 2 inch format is preferred
• Ordering box quantities for ongoing care supply needs

Packaging and Handling

• Packaging: BX.
• Size: 4.55 X 2.3 Inch.
• Sterility: Sterile.
• Check the 2 inch x 2 inch dressing size against the wound care protocol or coverage needed.
• This item comes in a box quantity of 25, which may matter for replenishment planning.
• If your workflow specifies a particular dressing formulation, confirm that Dermagran's zinc-nutrient dressing formulation matches your preference.

FAQ

• Is this wound dressing sterile? Yes. Dermagran hydrophilic impregnated gauze wound dressing is sterile.
• What size is this gauze dressing? This dressing is 2 inch x 2 inch.
• How many dressings come in a box? Each box includes 25 dressings.
• Does this dressing include any specific formulation technology? Yes. The dressing includes a zinc-nutrient dressing formulation and balanced pH technology.

From Dermagran by Integra Lifesciences.